Altor BioScience's Series G Round

Altor BioScience raised a round of funding on July 19, 2016. Investors include Sanderling Ventures.

Altor BioScience is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immunotherapeutic agents for the treatment of cancer, viral infectio…

Articles about Altor BioScience's Series G Round: